Estifan® (Estifan®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceEchinacea Purple Herb ExtractEchinacea Purple Herb Extract
Similar drugsTo uncover
  • Dr. Theiss Echinacea tincture
    tincture inwards 
    Dr. Thais Naturwaren GmbH     Germany
  • Estifan®
    pills inwards 
    VIFITEH, CJSC     Russia
  • Echinacea purpurea extract liquid
    extract inwards 
    ALTAYVITAMINS, CJSC     Russia
  • Echinacea extract liquid
    extract inwards 
    PHARMSTANDART-TOMSKHIMFARM, OJSC     Russia
  • Echinacea
    granules n / az. 
    HOMEOPATHIC PHARMACY, LLC     Russia
  • Echinacea compositum CH
    solution w / m 
    Biologist Heilmittel Heel GmbH     Germany
  • Echinacea-plus
    granules n / az. 
    DOCTOR N, LLC     Russia
    • Dosage form: & nbspPills.
    Composition:

    Composition per one tablet

    Active component: Echinacea extract dry with the content of the sum of derivatives of oxycinnamic acids in terms of chicory acid 7% - 0.2 g.

    Auxiliary substances: Sugar, milk (lactose monohydrate) - 0.190 g, Potato starch - 0.100 g, Polyvinylpyrrolidone low molecular weight medical (povidone) - 0.005 g. Calcium stearate - 0.005 g.

    The weight of the tablet is 0.5 g.

    Description:

    Tablets are round biconvex with a risk from light brown to dark brown with lighter and darker patches.

    Pharmacotherapeutic group:Immunostimulating agent of plant origin.
    ATX: & nbsp

    L.03.A.X   Other immunostimulants

    Pharmacodynamics:

    The main active ingredients of the drug are derivatives of oxycinnamic acids (mainly chicory acid), polysaccharides, isobutyl amides and glycoproteins.

    Estifan® stimulates the activity of the cellular and humoral links of the immune system. The drug increases the phagocytic activity of neutrophils and macrophages, potentiates the production of interleukin-1 by macrophages, induces the transformation of B-lymphocytes into plasma cells, enhances antibody formation, B- and T-lymphocyte cooperation, and T helper activity.

    Pharmacokinetics:

    No data available.

    Indications:

    Treatment and prevention of diseases accompanied by immunodeficiency states, including chronic recurrent inflammatory diseases (chronic bronchitis, pneumonia, ENT diseases) with inefficiency or insufficient effectiveness of antibacterial and anti-inflammatory therapy.

    Contraindications:

    Increased individual sensitivity to the components of the drug, progressive systemic diseases (tuberculosis, leukemia, collagenosis, rheumatism, multiple sclerosis, AIDS, HIV infection, autoimmune diseases, widespread atherosclerosis),congenital intolerance to galactose, deficiency of lactase Lappa, glucose-galactose malabsorption.

    The drug is not recommended for use in children under the age of 18 due to lack of data on efficacy and safety.

    Carefully:

    Patients with diabetes mellitus and people on a diet with a reduced carbohydrate content.

    If you have any of these diseases, consult a doctor before taking the drug.

    Pregnancy and lactation:

    Use during pregnancy and during breastfeeding is possible only after consulting a doctor.

    Dosing and Administration:

    Inside, adults 1-2 tablets 3 times a day after meals.

    In the acute phase of the disease, the drug is prescribed in combination with antibacterial therapy 2 tablets 3 times a day for 5 days, then 1 tablet 3 times a day for 10 to 20 days, depending on the nature and severity of the disease.

    In the phase of remission appoint 1-2 tablets 3 times a day for 10-20 days. If necessary, the course of treatment can be repeated after 2-3 weeks.

    Side effects:

    Allergic reactions (skin hyperemia, skin rash, face swelling), shortness of breath, sweating, lowering of blood pressure.

    If any of the side effects indicated in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.

    Overdose:

    So far, no cases of overdose have been reported.

    Interaction:

    It is possible to use simultaneously with antibiotics and other antimicrobial drugs. Incompatible with immunosuppressants.

    Special instructions:

    Patients with diabetes should take into account that one tablet of the drug contains about 0.29 grams of carbohydrates (0.024 XE).

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the performance of potentially hazardous activities requiring special attention and quick reactions (vehicle management, working with moving mechanisms, dispatcher and operator work, etc.).

    Form release / dosage:Tablets 200 mg.
    Packaging:

    For 10 tablets in a planar cell package. 1, 2 or 3 contour mesh packages together with instructions for use in a pack of cardboard.

    Storage conditions:

    In a dry, protected from light place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:P N003884 / 01
    Date of registration:12.01.2010
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp21.10.2015
    Illustrated instructions
      Instructions
      Up